the validity of these predictions was confirmed by plasma concentration measurements of trimethoprim and sulfamethoxazole in six patients undergoing gynecological surgery , who received co-trimoxazole ( 160 mg of trimethoprim , 800 mg of sulfamethoxazole ) postoperatively by constant-rate intravenous infusion over a 4-h period .
C0041041
trimethoprim
C0041044
co-trimoxazole